Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 70
Filtrar
1.
Prague Med Rep ; 124(1): 16-32, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36763828

RESUMEN

Odontogenic infections are the most common infectious and inflammatory diseases of the maxillofacial area and problem of the causative pathogen identification is an actual task, part of a permanent process of updating and modernization of treatment and diagnostic protocols and standards. In presented study a purulent exudate from 13 patients with acute purulent odontogenic intraoral lesions was studied by bacteriological method with detection of sensitivity to antibacterial agents. Bacteriological studies showed that genus Streptococcus predominated in 69.23% cases. Pathogenic microorganisms in clinically significant concentrations (105 per 1 ml and above) (Streptococcus and Staphylococcus) were resistant to Tetracycline and Doxycycline, had moderate sensitivity to macrolides in 22.22% and resistance in 77.78%. Amoxicillin/clavulanate caused effective growth retardation in 22.22% cases and moderate delay - in 77.78% without cases of resistance. Sensitivity to cephalosporins was detected in 50.00% cases, moderate sensitivity - in 38.89%, resistance - in 11.11%. Fluoroquinolones were the most effective - sensitivity in 72.22% cases, moderate sensitivity - in 22.22%, resistance - in 5.56%. The most effective fluoroquinolones were Moxifloxacin and Ciprofloxacin. The highest resistance to antifungal agents was shown by genus Candida, antifungal susceptibility was observed only in 20.00% cases. The microbiota of purulent odontogenic inflammation in the oral cavity was identified in clinically significant concentrations in only 61.54% cases with predominance of Streptococcus. The most effective antibacterial agents for odontogenic purulent process may be considered among cephalosporins and fluoroquinolones. There is a need to repeat similar studies in other regions of Ukraine and at other times of the year.


Asunto(s)
Antibacterianos , Periostitis , Humanos , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Absceso/tratamiento farmacológico , Periostitis/tratamiento farmacológico , Moxifloxacino , Cefalosporinas , Boca
2.
Pediatr Infect Dis J ; 41(1): e10-e15, 2022 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-34711782

RESUMEN

BACKGROUND: Osteomyelitis with proliferative periostitis is a relatively uncommon inflammatory condition of the jaws, mainly characterized by periosteal formation of reactive bone. It primarily affects children and adolescences, also referred to as Garre's osteomyelitis, more frequently involving the molar region of the mandible. Cases lacking an obvious source of infection may have an immunologically mediated etiopathogenesis, falling under the spectrum of primary chronic osteomyelitis or chronic recurrent multifocal osteomyelitis (CRMO). CASE REPORT: Herein, we present a case of chronic osteomyelitis in a 6.5-year-old girl, who suffered from recurrent painful episodes of swelling of the mandible for the last 2 years, previously requiring hospitalization and administration of intravenous (IV) antibiotics and NSAIDs with limited responsiveness. The biopsy showed features consistent with osteomyelitis with proliferative periostitis. The patient was initially managed with an IV combination antibiotic regimen with only partial improvement. The possibility of an autoimmune mechanism in the context of primary chronic osteomyelitis or CRMO was considered, and immunosuppressive therapy (TNF inhibitor etanercept along with corticosteroids and methotrexate) was administered, resulting in clinical resolution. CONCLUSIONS: Osteomyelitis and its childhood variants are relatively rare and their management presents several challenges. Although typically treated with administration of antibiotics, possibly along with surgical intervention, other treatment modalities may be necessary for resilient and persistent cases. In a subset of cases, especially in the absence of local infectious factors, immunologically mediated mechanisms may play an important role and appropriate immunosuppressive therapy may be effective.


Asunto(s)
Inmunosupresores/uso terapéutico , Mandíbula/patología , Osteomielitis/complicaciones , Osteomielitis/tratamiento farmacológico , Periostitis/tratamiento farmacológico , Antibacterianos/uso terapéutico , Biopsia , Niño , Diagnóstico Diferencial , Manejo de la Enfermedad , Femenino , Humanos , Osteomielitis/diagnóstico , Periostitis/diagnóstico
3.
Clin Rheumatol ; 40(11): 4749-4757, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-33830360

RESUMEN

Psoriatic onycho-pachydermo periostitis (POPP) is characterized by psoriatic onychodystrophy, connective tissue thickening, and periostitis of the distal phalanges (DPs), producing a drumstick-like deformity. Our aim was to present the first case of POPP treated successfully with an IL-17 inhibitor, perform a literature review of its characteristics and treatment, and explore the possible pathogenesis. We conducted a systematic review of previously presented POPP cases. We present a patient with methotrexate (MTX)-resistant treatment POPP, who had significant resolution of symptoms and inflammatory lesions on post-treatment MRI with secukinumab 150 mg. We also identified 31 cases of POPP (27 males; mean age 44.9 years) in the literature review. There was great toe involvement in 24 cases, and distal interphalangeal (DIP) involvement in 14 cases, with frequent radiographically evident damage. Seventeen of 31 patients received systematic treatment other than biologics, mostly MTX, with no satisfactory results. Anti-TNF agents were used successfully in 5 cases, mostly after disease modifying anti-rheumatic drug (DMARD) failure. Imaging studies in nail psoriasis and DIP psoriatic arthritis have shown an anatomical link among the nail, the DP bone, and the DIP joint entheses, suggesting that POPP may be a subtype of nail disease with excessive involvement of DP tissues (nail, soft tissue, enthesis, and bone). IL-17 inhibition could be an alternative therapeutic option in DMARD-resistant cases of POPP. Conventional treatment achieves modest success, but anti-TNF agents appear to be much more effective. Based on imaging studies, POPP may be a particular subtype of nail disease.


Asunto(s)
Artritis Psoriásica , Enfermedades de la Uña , Periostitis , Adulto , Artritis Psoriásica/complicaciones , Artritis Psoriásica/diagnóstico por imagen , Artritis Psoriásica/tratamiento farmacológico , Humanos , Interleucina-17 , Masculino , Persona de Mediana Edad , Enfermedades de la Uña/tratamiento farmacológico , Periostitis/diagnóstico por imagen , Periostitis/tratamiento farmacológico , Inhibidores del Factor de Necrosis Tumoral
4.
Reumatismo ; 73(1): 44-47, 2021 Apr 19.
Artículo en Inglés | MEDLINE | ID: mdl-33874646

RESUMEN

Voriconazole is a fluorinated drug from the triazole group that is widely used in the prophylaxis and treatment of fungal infections in immunosuppressed patients. Chronic use of this medication can generate, as an adverse effect, a multifocal, asymmetric, diffuse and nodular periosteal reaction, associated with severe and disabling skeletal pain and elevated alkaline phosphatase and serum fluoride. Radiography is the imaging technique of choice for periostitis diagnosis. In general, clinical manifestations and radiographic findings disappear, when the drug is discontinued. We report the clinical case of a 44 year-old woman diagnosed with acute myeloid leukemia, who developed an invasive fungal infection treated with voriconazole after a stem cell transplant. Nine months after starting antifungal treatment, she manifested symptoms and radiological signs compatible with periostitis. Due to clinical suspicion, we decided to suspend voriconazole, with consequent resolution of clinical manifestations and radiological findings.


Asunto(s)
Periostitis , Adulto , Antifúngicos/efectos adversos , Femenino , Humanos , Periostitis/inducido químicamente , Periostitis/diagnóstico por imagen , Periostitis/tratamiento farmacológico , Radiografía , Triazoles/efectos adversos , Voriconazol/efectos adversos
5.
Am J Emerg Med ; 48: 378.e1-378.e2, 2021 10.
Artículo en Inglés | MEDLINE | ID: mdl-33892938

RESUMEN

We present the case of a 2-month-old adopted female seeking evaluation in the pediatric emergency department due to a one-day history of decreased right arm movement and fussiness. The physical exam was largely unremarkable with the exception of decreased spontaneous movement of the right upper extremity, obvious discomfort with passive movement and subtle edema of the forearm. Because of concern for non-accidental trauma, plain films were obtained which revealed no signs of traumatic injury. Subsequently, a broader investigation ensued with infectious etiologies in mind. Laboratory evaluation demonstrated anemia, transaminitis, and elevated inflammatory markers. These abnormalities led to the consideration of congenitally acquired infections, specifically syphilis, and serologies were confirmatory. Ultimately, the infant was diagnosed with Pseudoparalysis of Parrot - a rare musculoskeletal manifestation secondary to painful syphilitic periostitis. As Emergency Medicine physicians, it is important to be aware of the growing burden of syphilis infection and reacquaint ourselves with its numerous presentations in the young infant.


Asunto(s)
Periostitis/diagnóstico por imagen , Sífilis Congénita/diagnóstico , Antibacterianos/uso terapéutico , Niño Adoptado , Codo/diagnóstico por imagen , Femenino , Humanos , Lactante , Penicilinas/uso terapéutico , Periostitis/tratamiento farmacológico , Radio (Anatomía)/diagnóstico por imagen , Sífilis Congénita/tratamiento farmacológico , Cúbito/diagnóstico por imagen
7.
Quintessence Int ; 49(3): 219-226, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29399678

RESUMEN

Chronic non-suppurative osteomyelitis (CNSO) is a chronic bone disease and may be associated with a reparative periosteum entity called proliferative periostitis (PP). This condition rarely affects the maxillofacial region. Mandibular cases were already described for an infectious dental cause, often with an "onion skin" radiographic aspect, but some rare reported cases showed no obvious etiology. They represent a challenge for diagnosis because of possible misdiagnosis leading to unsuccessful or inappropriate treatment attempts. An uncommon case of mandibular CNSO associated with PP in a 9-year-old boy with no obvious infectious or inflammatory causes is reported. Clinical and radiographic examinations revealed a swelling in the left hemimandible, associated with multiple osteolytic areas inside both medullary and newly formed periosteal bone and cortical bone perforations. Recovery signs were seen after a 22-month follow-up period, and radiographic signs of bone healing were observed. From this new case report, a review of the literature was performed on reported cases of mandibular CNSO with PP, and discussed the etiological, clinical, radiologic, and therapeutic aspects of this pathology. This work highlights the importance of considering CNSO with PP in the differential diagnosis of one-sided painless mandibular swellings, even in the absence of an obvious cause.


Asunto(s)
Enfermedades Mandibulares/diagnóstico , Osteomielitis/diagnóstico , Periostitis/diagnóstico , Antibacterianos/uso terapéutico , Niño , Enfermedad Crónica , Diagnóstico Diferencial , Diagnóstico por Imagen , Humanos , Masculino , Enfermedades Mandibulares/tratamiento farmacológico , Osteomielitis/tratamiento farmacológico , Periostitis/tratamiento farmacológico
8.
Toxicon ; 141: 15-17, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-29146176

RESUMEN

Local anesthesia is an effective method to control pain. Neosaxitoxin is a phycotoxin whose molecular mechanism includes a reversible inhibition of voltage-gated sodium channels at the axonal level, impeding nerve impulse propagation. The present study was designed to evaluate the clinical efficacy of Neosaxitoxin as a local long-acting pain blocker in horse bucked shins, and it was found to effectively control pain. While Neosaxitoxin and Gonyautoxin, another Paralytic Shellfish Poison (PSP) toxin, have been successfully used in humans as long-lasting pain blockers, this finding marks the first time a PSP has been shown to have an established effect in veterinary medicine.


Asunto(s)
Anestésicos Locales/uso terapéutico , Enfermedades de los Caballos/tratamiento farmacológico , Dolor/veterinaria , Periostitis/veterinaria , Saxitoxina/análogos & derivados , Anestésicos Locales/administración & dosificación , Animales , Caballos , Infusiones Subcutáneas/veterinaria , Cojera Animal/tratamiento farmacológico , Dolor/tratamiento farmacológico , Periostitis/tratamiento farmacológico , Saxitoxina/administración & dosificación , Saxitoxina/uso terapéutico
9.
Clin Exp Rheumatol ; 35(3): 516-517, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28339360

RESUMEN

OBJECTIVES: In 1966, Goldbloom et al. described two children who developed a peculiar clinical picture characterized by intermittent daily bone pain in the lower limbs, fever spikes, increased acute phase reactants and dysproteinaemia. The syndrome occurred two weeks after a group A ß-haemolytic streptococcus infection. So far, only a few cases have been reported in the medical literature in English. METHODS: We report two further cases of Goldbloom's syndrome with a review of the literature in English. RESULTS: Our two patients lived in the same Italian region and presented their syndrome onset a week apart. Early use of STIR MRI revealed an atypical metaphyseal hyperintensity in the femurs and tibias. X-ray showed periosteal hyperostosis. A short cycle of corticosteroids led to rapid recovery of symptoms and disappearance of bone changes. CONCLUSIONS: The reported cases highlight a likely under-recognised post-streptococcal inflammatory periosteal reaction and emphasise the diagnostic utility of the newer imaging modalities.


Asunto(s)
Fémur/diagnóstico por imagen , Hipergammaglobulinemia/sangre , Hipoalbuminemia/sangre , Imagen por Resonancia Magnética , Periostitis/diagnóstico por imagen , Infecciones Estreptocócicas/complicaciones , Tibia/diagnóstico por imagen , Corticoesteroides/uso terapéutico , Biomarcadores/sangre , Niño , Diagnóstico Precoz , Femenino , Fémur/microbiología , Humanos , Hipergammaglobulinemia/diagnóstico , Hipergammaglobulinemia/tratamiento farmacológico , Hipergammaglobulinemia/microbiología , Hipoalbuminemia/diagnóstico , Hipoalbuminemia/tratamiento farmacológico , Hipoalbuminemia/microbiología , Periostitis/tratamiento farmacológico , Periostitis/microbiología , Valor Predictivo de las Pruebas , Prednisona/uso terapéutico , Infecciones Estreptocócicas/diagnóstico , Infecciones Estreptocócicas/microbiología , Síndrome , Tibia/microbiología , Resultado del Tratamiento
10.
Am J Trop Med Hyg ; 96(5): 1039-1041, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28193743

RESUMEN

AbstractThe etiologic agent of yaws, Treponema pallidum subsp. pertenue, causes a multistage infection transmitted by nonsexual contact with the exudates from active lesions. Bone lesions in the form of osteoperiostitis are common and occur in numerous bones simultaneously in early stages. Although a multinational eradication campaign with mass administration of intramuscular benzathine benzylpenicillin in the 1950s greatly reduced its global incidence, a resurgence of yaws has occurred since around 2000 in western and central Africa and the Pacific Islands. The finding that a single oral dose of azithromycin (30 mg/kg) was as effective as benzathine benzylpenicillin prompted renewed interest by World Health Organization in 2012 toward eradication of this infection by 2020. We previously reported the excellent response to benzathine benzylpenicillin therapy for yaws osteoperiostitis. Herein, we document a confirmed case of yaws with osteoperiostitis successfully treated with single-dose azithromycin and discuss the pathology of yaws periostitis and comment on the implications of this in light of the new campaign toward yaws eradication.


Asunto(s)
Antibacterianos/uso terapéutico , Azitromicina/uso terapéutico , ADN Bacteriano/aislamiento & purificación , Periostitis/tratamiento farmacológico , Treponema pallidum/efectos de los fármacos , Buba/tratamiento farmacológico , Preescolar , Humanos , Pierna/diagnóstico por imagen , Pierna/microbiología , Pierna/patología , Masculino , Periostio/diagnóstico por imagen , Periostio/efectos de los fármacos , Periostio/microbiología , Periostio/patología , Periostitis/diagnóstico por imagen , Periostitis/microbiología , Periostitis/patología , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , Treponema pallidum/genética , Treponema pallidum/aislamiento & purificación , Muñeca/diagnóstico por imagen , Muñeca/microbiología , Muñeca/patología , Buba/diagnóstico por imagen , Buba/microbiología , Buba/patología
11.
Pediatr Ann ; 45(5): e176-9, 2016 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-27171806

RESUMEN

Acute mastoiditis (AM) is a relatively rare complication of acute otitis media (AOM). The most common pathogens include Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus. Pneumococcal vaccination and changes in antibiotic prescribing recommendations for AOM may change the incidence of AM in the future. Diagnosis of AM can be made based on clinical presentation, but computed tomography of the temporal bone with contrast should be considered if there is concern for complicated AM. Both extracranial and intracranial complications of AM may occur. Previously, routine cortical mastoidectomy was recommended for AM treatment, but new data suggest that a more conservative treatment approach can be considered, including intravenous (IV) antibiotics alone or IV antibiotics with myringotomy. [Pediatr Ann. 2016;45(5):e176-e179.].


Asunto(s)
Mastoiditis/microbiología , Otitis Media con Derrame/microbiología , Infecciones Neumocócicas/microbiología , Streptococcus pneumoniae/aislamiento & purificación , Absceso/diagnóstico por imagen , Absceso/tratamiento farmacológico , Absceso/microbiología , Enfermedad Aguda , Antibacterianos/uso terapéutico , Ceftriaxona/uso terapéutico , Femenino , Humanos , Lactante , Apófisis Mastoides/patología , Apófisis Mastoides/cirugía , Mastoiditis/diagnóstico , Mastoiditis/terapia , Otitis Media con Derrame/tratamiento farmacológico , Periostio/diagnóstico por imagen , Periostitis/diagnóstico por imagen , Periostitis/tratamiento farmacológico , Periostitis/microbiología , Infecciones Neumocócicas/tratamiento farmacológico , Tomografía Computarizada por Rayos X
13.
J Dermatol ; 42(10): 996-8, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26010891

RESUMEN

Ustekinumab is a human monoclonal antibody that specifically binds to the p40 subunit of interleukin (IL)-12 and IL-23, inhibiting the activity of both cytokines, thereby blocking the T-helper (Th)1 and Th17 inflammatory pathways. While biologic agents have dramatically changed the strategies of psoriasis treatment, increasing cases of autoimmune diseases during the use of such agents have been reported. We experienced a case of bullous pemphigoid occurring during treatment of a rare variant of psoriatic arthritis, psoriatic onycho-pachydermo periostitis with ustekinumab. Only six cases of autoimmune blistering diseases during treatment with biologic agents have ever been reported including our case, and we herein review the published work of these cases. Dermatologists must be attentive to the possibility of autoimmune blistering diseases during ustekinumab treatment.


Asunto(s)
Artritis Psoriásica/tratamiento farmacológico , Fármacos Dermatológicos/efectos adversos , Penfigoide Ampolloso/inducido químicamente , Periostitis/tratamiento farmacológico , Ustekinumab/efectos adversos , Humanos , Masculino , Persona de Mediana Edad
14.
Transpl Infect Dis ; 15(4): 424-9, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23663268

RESUMEN

Fungal infections are common in solid organ transplantation. An increasing number of transplant recipients receive antifungal therapy for prolonged duration owing to invasive fungal infections. Herein, we describe a diagnosis of periostitis as a complication of chronic use of voriconazole in a lung transplant recipient. The patient was diagnosed with probable pulmonary aspergillosis and was treated with oral voriconazole for a total of 9 months. Evidence of multifocal periostitis was observed in the axial and appendicular skeleton. Early recognition of this phenomenon is important to prevent unnecessary tests and procedures. Prompt discontinuation of voriconazole should result in improvement of symptoms.


Asunto(s)
Antifúngicos/efectos adversos , Enfermedades Pulmonares Fúngicas/tratamiento farmacológico , Trasplante de Pulmón/efectos adversos , Periostitis/microbiología , Aspergilosis Pulmonar/tratamiento farmacológico , Pirimidinas/efectos adversos , Triazoles/efectos adversos , Anciano , Antifúngicos/uso terapéutico , Quimioprevención , Femenino , Humanos , Enfermedades Pulmonares Fúngicas/complicaciones , Enfermedades Pulmonares Fúngicas/microbiología , Masculino , Periostitis/complicaciones , Periostitis/diagnóstico , Periostitis/tratamiento farmacológico , Aspergilosis Pulmonar/complicaciones , Aspergilosis Pulmonar/microbiología , Pirimidinas/uso terapéutico , Triazoles/uso terapéutico , Voriconazol
15.
Pediatr Dermatol ; 30(6): 758-60, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-22471702

RESUMEN

We describe a 3-month-old infant who presented to our institution with interleukin (IL)-1 receptor antagonist deficiency (DIRA), which consists of neutrophilic pustular dermatosis, periostitis, aseptic multifocal osteomyelitis, and persistently high acute-phase reactants. Skin findings promptly improved upon initiation of treatment with anakinra (recombinant human IL-1 receptor antagonist), and the bony lesions and systemic inflammation resolved with continued therapy.


Asunto(s)
Enfermedades Autoinflamatorias Hereditarias/tratamiento farmacológico , Proteína Antagonista del Receptor de Interleucina 1/uso terapéutico , Osteomielitis/tratamiento farmacológico , Periostitis/tratamiento farmacológico , Enfermedades Cutáneas Vesiculoampollosas/tratamiento farmacológico , Antirreumáticos/uso terapéutico , Femenino , Enfermedades Autoinflamatorias Hereditarias/complicaciones , Humanos , Lactante , Osteomielitis/etiología , Periostitis/etiología , Enfermedades Cutáneas Vesiculoampollosas/etiología
18.
Lepr Rev ; 83(1): 98-103, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22655475

RESUMEN

Florid reactive periostitis ossificans is a rare bone lesion usually occurring in the small, tubular bones of the hands and feet. This entity is a benign and aggressive periosteal reaction associated with soft tissue swelling that appears similar to a bone lesion that radiographically and clinically mimics an infectious or neoplastic process. Typically the lesions occurs in an adolescent or young adult and presents as a small area of painful swelling and erythema over the affected bone. The cause of florid reactive periostitis ossificans is not exactly known though many authors have postulated varied etiopathogenesis for the same condition. In this report, is a very rare and unusual example of this entity that has been observed in association with erythema nodosum leprosum (ENL) a type 2 lepra reaction in a Leprosy patient.


Asunto(s)
Eritema Nudoso/complicaciones , Lepra Lepromatosa/tratamiento farmacológico , Periostitis/complicaciones , Adolescente , Clofazimina/administración & dosificación , Dapsona/administración & dosificación , Eritema Nudoso/tratamiento farmacológico , Humanos , Leprostáticos/administración & dosificación , Lepra Lepromatosa/patología , Masculino , Osteítis/tratamiento farmacológico , Osteítis/patología , Periostitis/diagnóstico por imagen , Periostitis/tratamiento farmacológico , Periostitis/patología , Radiografía , Rifampin/administración & dosificación , Resultado del Tratamiento
19.
Rheumatol Int ; 32(5): 1449-52, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-21448639

RESUMEN

Psoriatic onycho-pachydermo-osteo/periostitis (POPP) syndrome is a rare form of psoriatic arthritis with a combination of (i) psoriatic onychodystrophy, (ii) connective tissue thickening, and (iii) periostitis of the distal phalanges. The treatment of the condition has generally been reported to be unsatisfactory with the traditional regimes. Here, we describe a case whom we believe is one presentation of POPP with extensive bone marrow edema of metacarpal bones without distinctive periostitis.


Asunto(s)
Artritis Psoriásica/diagnóstico , Enfermedades de la Médula Ósea/diagnóstico , Enfermedades del Tejido Conjuntivo/diagnóstico , Edema/diagnóstico , Huesos del Metacarpo/patología , Enfermedades de la Uña/diagnóstico , Periostitis/diagnóstico , Artritis Psoriásica/tratamiento farmacológico , Artritis Psoriásica/patología , Enfermedades de la Médula Ósea/tratamiento farmacológico , Enfermedades de la Médula Ósea/patología , Enfermedades del Tejido Conjuntivo/tratamiento farmacológico , Enfermedades del Tejido Conjuntivo/patología , Quimioterapia Combinada , Edema/tratamiento farmacológico , Edema/patología , Humanos , Inmunosupresores/uso terapéutico , Imagen por Resonancia Magnética , Masculino , Huesos del Metacarpo/diagnóstico por imagen , Huesos del Metacarpo/efectos de los fármacos , Enfermedades de la Uña/tratamiento farmacológico , Enfermedades de la Uña/patología , Periostitis/tratamiento farmacológico , Periostitis/patología , Síndrome , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , Adulto Joven
20.
Clin Infect Dis ; 52(6): 771-4, 2011 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-21367729

RESUMEN

We describe the clinical and radiological manifestations and outcome after treatment of 7 children who received a diagnosis of early yaws osteoperiostitis. Osteoperiostitis occurred some weeks after the primary infection, and the most common finding was hypertrophic periostitis of long bones. All treated patients had excellent responses to benzyl-penicillin therapy.


Asunto(s)
Periostitis/diagnóstico , Periostitis/patología , Buba/complicaciones , Buba/patología , Antibacterianos/administración & dosificación , Huesos/patología , Niño , Preescolar , Femenino , Humanos , Masculino , Penicilina G/administración & dosificación , Periostitis/diagnóstico por imagen , Periostitis/tratamiento farmacológico , Radiografía , Factores de Tiempo , Resultado del Tratamiento , Treponema pallidum/aislamiento & purificación , Buba/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA